Covered Call Taken Away
This is a note of little consequence, but I’ve promised to share my portfolio when it comes to equity trades so I thought I should let you know that I sold the vast majority of my Intel (INTC) shares...
View ArticleAnnual Review: Foreign Speculations
There are a few overseas stocks on our speculations list that I haven’t covered yet as we begin this new year, so let’s catch up on those: Brazil Fast Food (BOBS) — Hold at $17. Next quarter may be bad...
View Article“How the Navy’s Annual $16.8 Billion ‘Bet’ Can Make You Rich”
The spiel is convincing, as they all are — the folks at Rogue Capitalists Trader, which appears to be a pretty new service from the Contrarian Profits folks, are teasing us that they’ve got the inside...
View ArticleAnnual Review — Speculations
I’ve been putting out my updated thoughts on each of our Irregulars spreadsheet companies (mostly past “Idea of the Month” stocks) over the last couple weeks, and now that I’m done looking at all of...
View ArticleCrisis and Opportunity’s “Breakthrough technology turns air, sunlight, coal,...
I haven’t sniffed around in one of Christian DeHaemer’s teaser pitches for a while, so this one that a lot of folks have been sending in bumped itself to the top of our pile today. And it sounds, of...
View Article“Lord of the Rigs: How This Deep-Sea Landlord Forces Big Oil to Fund Your...
Keith Kohl has been mostly teasing his Bakken shale oil picks in recent months as he sniffs around for new subscribers to Energy Investor, but lately we’ve seen a new ad campaign that teases a stock he...
View Article“The Next McDonald’s … One Stock You Must Buy in 2014″
I’ll warn you up front: if you’ve been sailing the seas with us here on the good ship Gumshoe for more than a couple years, you’ve already seen this one. But Benjamin Shepherd at the Global Investment...
View ArticleAnnual Review — Watchlist
Just as I catch up on some of the favorite stocks in the Gumshoe universe at least once each year, so too I need to check in with all of our watchlist companies — but first, a trade to note for you:...
View ArticleWhat are the “Upturn Millionaires” 10-baggers?
Geez, the teaser patch is a little thin this morning — it makes me fear that perhaps we haven’t been putting out enough fertilizer or something, what ever will your friendly neighborhood Gumshoe do if...
View Article“Travis, can you break this please?”
Who can resist an entreaty like that? Several intrepid Gumshoe readers sent along pleas for a solution to this one today … and we are, as always, happy to oblige. I know you have a choice when it comes...
View Article“Texas Oil & Gas Royalty Trusts Are An Income Investor’s Dream And The Best...
It’s fair to say that we get more than our share of teasers for commodity and natural resources stocks here at Stock Gumshoe — those kinds of stocks take up a big chunk of the newsletter world, with...
View ArticleWhat’s Lundin’s February “Gold Investor” Stock?
Brien Lundin edits a newsletter called Gold Investor, and he also writes a lot of free stuff and runs the New Orleans Investor Conference, so most gold-focused or mining investors will know his name....
View Article$82 billion opportunity disappearing soon? (Frank Curzio’s Phase 1)
Several intrepid readers sent this pitch flying my way while we were digging out of our latest snowstorm, and I figured a nice little panic about an $82 billion “missed opportunity” ought to warm me...
View Article“This small niche player has a ‘first mover’ advantage on the complete cure...
I haven’t been doing a lot with my personal portfolio over the past month — sometimes, even when the market makes you feel twitchy, I do manage to stick to the adage that has most often provided good...
View Article“The Tiny Company About to Go ‘Public’ With True Fountain of Youth” (“Dr....
[Ed note: This article was originally published in June, 2013 when the shares of the stock teased, Alnylam (ALNY) were around $30 and the Oxford Club was saying that the first person to live to 1,000...
View Article“Blue Blood”— Which “Tiny Biotech Owns Only Source of Rare Cancer-Curing...
A couple days ago we started getting a deluge of new queries from subscribers about something called “blue blood” — teasing a company that was about to sign contracts with major pharmaceutical...
View ArticleA Weak Quarter … But Nice Spike from Sad Patent Lawyers
Invensense (INVN), which in January I noted was a reasonable buy up to $20 or so but not one to load up on right before earnings (which were two weeks ago), reported pretty tepid earnings and forecast...
View ArticleWill FT-900 Bring about the “next 9/11″ in April, 2014? What is Jeff Opdyke...
Jeff Opdyke has a pretty inflammatory ad going around these days for The Sovereign Investor, it’s all about how the consistent export of gold from the US — as reported in form FT-900 — will lead to...
View Article“Healthcare’s Next Big Game-Changer”
We’re well on our way to piling another foot of snow here atop Gumshoe Mountain, so I’ll keep today’s missive brief — there’s sledding to do, after all, and little Gumshoes out of school and craving...
View ArticleLeeb’s “Secret to Doubling Your Money on Wall Street”
“My Top-Secret Recommendation — Already Growing at 20% — Is Positioned to Score Huge Profits from the UAV Drone and 3-D Markets” That was the part of Stephen Leeb’s latest pitch that caught my...
View Article